PFE Pfizer Inc stock chart & analysis
Conviction 62HealthcareScan · Fri, Nov 6, 2026Pfizer Inc (PFE) closed at $29.39 (-1.64%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 50, RS Rating 84, -6.5% from its 52-week high, +18.0% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Financials as of Sun, Sep 27, 2026 · quarterly.
PFE technical analysis
Trend
PFE is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 2.3% above the 50-day ($28.74) and 9.2% above the 200-day ($26.91). ADX(14) at 29 points to a strong, established trend. It meets 5 of 8 trend-template criteria.
Momentum
RSI(14) is 50, in the bearish half of its range. MACD crossed below its signal line one session ago. Its RS Rating of 84 puts its weighted 12-month performance ahead of about 84% of the US market.
Volume and volatility
Volume on the latest session ran 1.3× its 20-day average. It trades about $1.0B a day on average. ATR(14) is $0.7638, 2.6% of price — its typical daily range.
Key levels
The chart pattern's support is $27.23 and its resistance $30.16. The 52-week range is $23.62 to $31.44; price is 6.5% below the high and 24.4% above the low. The VWAP anchored at the 52-week high is $29.82, above price.
Performance
PFE returned -3.7% (1 week), +5.6% (1 month), +8.6% (3 months), +14.4% (6 months), +19.4% (1 year), +18.0% (year to date).
About Pfizer Inc
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Pharmaceutical Preparations · Listed 1951 · 75,000 employees
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upOct 291 scan
- Breaking out nowOct 301 scan
Congress activity
Disclosed STOCK Act trades in PFE · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Carol Devine Miller house · R · WV · traded 2025-03-10 | Sell | $15K–$50K | 2025-03-10 | 2026-08-13 | |
 Michael Rulli house · R · OH · traded 2024-11-26 | Sell | $1K–$15K | 2024-11-26 | 2026-08-07 | |
 Thomas H Tuberville senate · traded 2024-05-03 | Sell | $15K–$50K | 2024-05-03 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-24 | Sell | $50K–$100K | 2026-03-24 | 2026-07-21 | |
Thomas H Tuberville senate · traded 2026-06-08 | Sell | $15K–$50K | 2026-06-08 | 2026-07-16 | |
 Gilbert Cisneros house · CA · traded 2026-02-10 | Buy | $1K–$15K | 2026-02-10 | 2026-03-06 | |
 James French Hill house · AR · traded 2025-12-31 | Sell | $100K–$250K | 2025-12-31 | 2025-12-31 | |
Gilbert Cisneros house · D · CA · traded 2025-08-05 | Sell | $1K–$15K | 2025-08-05 | 2025-09-12 | |
 Lisa McClain house · R · MI · traded 2025-08-04 | Sell | $1K–$15K | 2025-08-04 | 2025-09-12 | |
Lisa McClain house · R · MI · traded 2025-07-16 | Buy | $1K–$15K | 2025-07-16 | 2025-08-13 |
Insider activity
SEC Form 4 transactions in PFE · open-market 3 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BOURLA ALBERT Chairman & CEO · Phantom Stock Units SSP · 2026-10-30 | Grant | 20 | $610 | 2026-10-30 | 2026-11-03 |
Buckley Mortimer J Director · Phantom Stock Units · 2026-09-25 | Grant | 1.31K | $37K | 2026-09-25 | 2026-09-29 |
Echevarria Joseph Director · Phantom Stock Units · 2026-09-25 | Grant | 1.61K | $46K | 2026-09-25 | 2026-09-29 |
BOURLA ALBERT Chairman & CEO · Phantom Stock Units SSP · 2026-08-31 | Grant | 21 | $598 | 2026-08-31 | 2026-09-01 |
BOURLA ALBERT Chairman & CEO · Phantom Stock Units SSP · 2026-08-14 | Grant | 22 | $589 | 2026-08-14 | 2026-08-17 |
BOURLA ALBERT Chairman & CEO · Common Stock · 2026-08-12 | Buy | 38K | $1.0M | 2026-08-12 | 2026-08-12 |
BLAYLOCK RONALD E Director · Common Stock · 2026-08-05 | Buy | 39.23K | $999K | 2026-08-05 | 2026-08-05 |
Buckley Mortimer J Director · Common Stock · 2026-08-05 | Buy | 37.63K | $960K | 2026-08-05 | 2026-08-05 |
BOURLA ALBERT Chairman & CEO · Phantom Stock Units SSP · 2026-07-15 | Grant | 24 | $596 | 2026-07-15 | 2026-07-16 |
BOURLA ALBERT Chairman & CEO · Phantom Stock Units SSP · 2026-07-09 | Grant | 84 | $2K | 2026-07-09 | 2026-07-13 |
SEC filings
EDGAR filings in PFE · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.